The “Impacting Cancer Health Disparities and Facilitating Cancer Health Equity in Breast, Multiple Myeloma, and Prostate Cancers in Underserved and Minority Populations: The cancer-Community Awareness Access Research & Education II (c-CARE II) Initiative” team is located at the Medical College of Georgia’s main campus in Augusta, GA (Richmond County) and is led by Dr. Martha Tingen. The Study is a collaboration with the Georgia Cancer Center.
Organization Overview
The c-CARE project framework was originally introduced in 2015, and utilizes the “train the trainer” method to deliver culturally-tailored educational intervention sessions at various community sites. Funding for the c-CARE II project was obtained through a grant from the Bristol Myers Squibb Foundation, $3.38M.
Target Area & Objectives Site Locations Community Health Workers Project Contacts Co-Investigators
The c-CARE II project seeks to recruit 600 African American (AA) adults (over 18 years of age) at 20 faith-based sites, rural and urban, from five Central Savannah River Area (CSRA) counties with a high percentage of AAs to include Burke, Jefferson, McDuffie, Richmond, and Wilkes.
In general, the study target area ranks poorly in multiple socio-economic and health indicators, and the population has an increased risk for preventable cancer and poorer cancer outcomes.
The c-CARE II initiative is a research study designed to improve cancer outcomes—specifically breast, multiple myeloma, and prostate—in minority and underserved populations in a sustainable and collaborative community-based approach.
Rev. Favors and CHWs
This will be achieved by:
The c-CARE Team, Pastors, and CHWs were featured in a podcast at the Georgia Cancer Center.
The c-CARE II project has strengthened trust between communities and the healthcare system by training Community Health Workers (CHWs) chosen by pastors to serve as trusted bridges to care. Equipped with skills in cancer prevention, early detection, and culturally sensitive communication, CHWs create supportive environments where participants feel safe to ask questions and engage in preventive care.
Participants will attend five 90-minute c-CARE II curriculum sessions, which emphasize
prevention, screening, and early detection behaviors. We will assess modifiable behavioral
risk factors, including tobacco use and obesity; we will implement an obesity intervention
for all participants, and provide navigation to tobacco cessation resources if the
participant is motivated to do so. Also, we will assess non-modifiable risks through
navigation to genetic testing for those meeting established eligibility criteria and
willing to do so. The genetic testing will be an optional component of the study.
c-CARE II also has a global component and we work with six countries in Africa.
Dr. Mina Tsai
Dr. Anand Jillella
Dr. Priyanka Raval
Dr. Zachary Klaassen
Dr. John Henson, IV
